TICKERNERD
Menu
ITOCITOCHealthcare · Medical Devices

ITOC Stock Forecast: iTonic Holdings Ltd. Price Predictions for 2026-2027

Last close, 8 Oct 2026
$4.02
−3.13% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 18 of 100 as at 8 Oct 2026 — in the weakest quartile.

Market cap
$29.4M
Ticker Nerd rank
18 / 100
Median analyst target
—
Analysts covering
—
Total return, dividends reinvested
1W
−12.2%
1M
−18.2%
YTD
−40.3%
1Y
−64.2%
From 52W high
−72.1%
From 52W low
+0.9%
$4
$14
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ITOC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores iTonic Holdings Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 8 Oct 2026
18 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
86
Growth
50
Accruals
48
Volatility
35
Momentum
34
Revisions
25
Value
20
Quality
20
Issuance
16

Size (86): Smaller than most of the companies we track.

Issuance (16): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ITOC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ITOC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$4$6$8$10$12Jan 26Apr 26Jul 26Oct 26ITOC

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ITOC appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

ITOC vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 8 Oct 2026, iTonic Holdings Ltd. returned −64.2% against +16.2% for the S&P 500, dividends included.

ITOC vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120Jan 26Apr 26Jul 26Oct 26ITOCS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ITOC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

iTonic Holdings Ltd. (ITOC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
52.3×

Cheaper than 5% of US stocks

Price / book
19.8×

Cheaper than 4% of US stocks

EV / EBITDA
−3.7×

Cheaper than 77% of US stocks

Growth & margins
Revenue growth (YoY)
49.5%

Higher than 86% of US stocks

Earnings growth (YoY)
—
Gross margin
—
Operating margin
−5036.1%

Higher than 3% of US stocks

Net margin
62.6%

Higher than 97% of US stocks

Returns & dividend
Return on equity
−67.0%

Higher than 18% of US stocks

Return on assets
−32.3%

Higher than 13% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

iTonic Holdings Ltd. (ITOC) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • iTonic Holdings Ltd. has a market value of $29.4M and an enterprise value of $29.5M.

  • Shares outstanding: 17.1M.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • iTonic Holdings Ltd. employs 7 people.

market figures as at 9 Oct 2026

Data provided by Twelve Data

Peers

ITOC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
ITOCiTonic Holdings Ltd.$29.4M
18
ARAYAccuray, Inc.$28.7M
33
NSYSNortech Systems, Inc.$31.5M
81
BDMDBaird Medical Investment Holdings Ltd.$25.3M
22
MODDModular Medical, Inc.$25.3M
14
ELUTElutia, Inc.$36.6M
29
QTIQT Imaging Holdings, Inc.$38.1M
21

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own iTonic Holdings Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ITOC news & analysis

iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026

GlobeNewsWire · 2 Oct 2026neutral

iTonic Holdings Ltd announced that shareholders approved a 16-for-1 consolidation of its Class A and Class B ordinary shares at an EGM on September 9, 2026, along with a related increase in authorized share capital. The consolidation, effective October 6, 2026, will combine every sixteen issued and unissued shares into one share, with par value adjusted from US$0.0001 to US$0.0016 per share.

Why it matters — ITOC watchers would care because the share consolidation changes the company's share structure and per-share par value, potentially affecting share price and outstanding share count.

Bronstein, Gewirtz & Grossman LLC Urges iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd.

GlobeNewsWire · 29 Sept 2026negative

Bronstein, Gewirtz & Grossman LLC announced that a class action lawsuit has been filed against iTonic Holdings Ltd., formerly known as Pheton Holdings Ltd. The investor-rights law firm is publicizing the litigation on behalf of shareholders.

Why it matters — ITOC watchers would care because a class action lawsuit against the company introduces legal and reputational risk that could weigh on investors.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 29, 2026 in iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) Lawsuit - ITOC, PTHL

GlobeNewsWire · 28 Sept 2026negative

A securities class action has been filed against iTonic Holdings Ltd (formerly Pheton Holdings Ltd), alleging the company failed to disclose the documented microcap manipulation history of the gatekeepers who took it public. Law firm Levi & Korsinsky reminds shareholders of a lead plaintiff deadline of September 29, 2026.

Why it matters — ITOC watchers would care because the company faces a securities lawsuit over alleged nondisclosure surrounding its public listing, with a shareholder lead plaintiff deadline approaching in September 2026.

iTONIC URGENT INVESTOR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds iTonic Holdings Ltd Investors to Contact the Firm Seeking Lead Plaintiff Role Before September 28th

GlobeNewsWire · 25 Sept 2026negative

Bragar Eagel & Squire, P.C. issued an urgent investor deadline alert reminding iTonic Holdings Ltd. (ITOC) investors who suffered losses to contact the firm regarding a lead plaintiff role before September 28th. Litigation Partner Brandon Walker is encouraging affected investors to discuss their options directly.

Why it matters — The alert signals potential securities litigation involving ITOC and prompts affected investors to consider participating before the stated deadline.

Bronstein, Gewirtz & Grossman LLC Urges iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd.

GlobeNewsWire · 25 Sept 2026negative

Bronstein, Gewirtz & Grossman LLC announced that a class action lawsuit has been filed against iTonic Holdings Ltd. (formerly Pheton Holdings Ltd.). The investor-rights law firm is informing shareholders of the legal action.

Why it matters — ITOC watchers would care because the company faces legal proceedings in the form of a class action lawsuit, which could expose it to liabilities and reputational risk.

FAQ

Frequently asked questions about ITOC stock

How does Ticker Nerd's model rank ITOC?

As at 8 Oct 2026, iTonic Holdings Ltd. ranks 18 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (86 of 100).

What is the ITOC stock forecast for 2030?

No analyst covering iTonic Holdings Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ITOC are extrapolating price history, which says nothing about the business.

How has ITOC stock performed over the past year?

iTonic Holdings Ltd. returned -64.2% over the 12 months to 8 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does iTonic Holdings Ltd. do?

iTonic Holdings Ltd. is a healthcare solutions company focused on brachytherapy, a targeted form of radiation therapy used in cancer treatment.

What is the latest news on ITOC?

The most recent item we track (GlobeNewsWire, 2 Oct 2026): "iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026". iTonic Holdings Ltd announced that shareholders approved a 16-for-1 consolidation of its Class A and Class B ordinary shares at an EGM on September 9, 2026, along with a related increase in authorized share capital. The consolidation, effective October 6, 2026, will combine every sixteen issued and unissued shares into one share, with par value adjusted from US$0.0001 to US$0.0016 per share.

Company

About iTonic Holdings Ltd.

iTonic Holdings Ltd. is a healthcare solutions company focused on brachytherapy, a targeted form of radiation therapy used in cancer treatment. Through its operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., the company develops and commercializes treatment planning software and related devices designed to support precise radioactive source placement and dose planning. Its core product, FTTPS, is used to help clinicians define target volumes, prescribe doses, and protect nearby organs during treatment. The company also offers medical auxiliary supplies, including seed implant needles, computer workstations, and patient positioning devices, which support clinical workflows in brachytherapy procedures. Headquartered in Beijing, China, iTonic Holdings Ltd. serves the medical technology market with solutions aimed at improving planning accuracy and treatment delivery in oncology care.

CEO Mr. Jianfei Zhang · 7 employees · China · https://www.ftzy.com.cn